Home › Johnson & Johnson multiple myeloma drug wins accelerated OK
 

Keywords :   


Johnson & Johnson multiple myeloma drug wins accelerated OK

2015-11-17 00:18:51| Biotech - Topix.net

" A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and have few options left. Darzalex is the first biologic drug and first monoclonal antibody " a genetically engineered drug designed to target diseased tissue and spare healthy cells " approved for multiple myeloma.

Tags: ok multiple drug johnson

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
13.05Melinda French Gates to quit Gates Foundation
13.05BASF in South Carolina Joins with Make-A-Wish
13.05PCMC addresses latest printing trends at \'Power Packs Live\'
More »